Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2014-02-10 Regulatory Filings
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2014
Regulatory Filings Classification · 95% confidence The document is a press release dated February 10, 2014, announcing the completion of a strategic alliance ('The BioAg Alliance') between Novozymes and Monsanto. It details the terms of the collaboration and includes standard boilerplate sections like contact information, company descriptions, and cautionary statements regarding forward-looking information. This type of announcement, detailing a significant business transaction (a strategic alliance/joint venture closing), does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a significant corporate event announcement. Since it is not a standard regulatory filing like a 10-K or a specific financial report, and it is not a proxy statement (DEF 14A) or a director's dealing (DIRS), the most appropriate general category for a significant, non-standard corporate announcement that isn't a simple earnings release or dividend notice is the general Regulatory Filings fallback category (RNS), as it serves as a public disclosure of a material event.
2014-02-10 English
Major Shareholding Notification 2014
Major Shareholding Notification Classification · 99% confidence The document explicitly details a 'Sale of shares' transaction involving a major shareholder (Novo A/S) related to the chairman of the board, including the volume, value, and trading date. This type of filing, reporting personal share transactions by company directors or closely related parties, directly corresponds to the definition of Director's Dealing. The relevant code is DIRS.
2014-02-10 English
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-02-10 Danish
Regulatory Filings 2014
Regulatory Filings Classification · 99% confidence The document text is extremely short (232 characters) and explicitly states that transactions are being reported 'in accordance with Section 28a of the Danish Securities Trading Act' concerning Novozymes B shares. Crucially, it directs the reader to 'Read the full announcement in PDF format.' This structure—a brief notification pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the content relates to specific transactions (though not explicitly director dealings, it's a regulatory disclosure), and it's a short announcement pointing elsewhere, RPA is the most appropriate classification based on the 'MENU VS MEAL' rule, as it is announcing the publication of the detailed filing. If the content were detailed insider trading reports, DIRS would apply, but here it's a regulatory notice of a transaction report.
2014-02-10 English
Regulatory Filings 2014
Regulatory Filings Classification · 99% confidence The document is very short (226 characters) and is written in Danish. It explicitly states that Novozymes is making public transactions according to Section 28a of the Securities Trading Act, referencing ISIN DK0060336014 and Novozymes B shares (NZYM B). It concludes by stating, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format). This structure—a brief notification pointing to a full PDF—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to transactions by insiders or related parties (implied by the reference to the Securities Trading Act and specific share codes), the most fitting category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, and the fact that it's a brief announcement pointing to a full document, it could also be a general Regulatory Filing (RNS). Director's Dealing (DIRS) is more specific to the content (transactions under the Securities Trading Act). I will classify it as DIRS, as the content is clearly about insider transactions, even if announced briefly.
2014-02-07 Danish
Director's Dealing 2014
Director's Dealing Classification · 99% confidence The document is dated February 7, 2014, and explicitly states it is a public disclosure ('offentliggør') according to the Danish Securities Trading Act ('Værdipapirhandelslovens paragraf 28a'). It details a transaction ('Salg af aktier' - Sale of shares) involving a related party ('Novo A/S') to a director ('formanden for Novozymes' bestyrelse'). This structure—reporting personal share transactions by directors and executives—directly matches the definition for Director's Dealing (DIRS). The document is short and contains specific transaction details, confirming it is a direct report of insider trading, not an announcement of a larger report.
2014-02-07 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.